Financings in Brief: Abaxis
This article was originally published in The Gray Sheet
Executive Summary
Abaxis: Nets $6.1 mil. from a private offering of 980,000 new common shares to a foreign investor. The blood analysis systems manufacturer says the proceeds will be used to commercialize its Piccolo portable blood analyzer and its VetScan veterinary products. Sunnyvale, California-based Abaxis recently entered a non-exclusive agreement with Baxter for distribution of the Piccolo, formerly known as the Epoc 2000, in the U.S. The system is scheduled for rollout in September, Abaxis says. The offering brings Abaxis' outstanding shares to 9.7 mil...